Grove Bank & Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-134
| Closed | -$9.47K | – | 861 |
|
2025
Q1 | $9.47K | Buy |
+134
| New | +$9.47K | ﹤0.01% | 591 |
|
2018
Q1 | – | Sell |
-72
| Closed | -$6K | – | 193 |
|
2017
Q4 | $6K | Sell |
72
-239
| -77% | -$19.9K | ﹤0.01% | 471 |
|
2017
Q3 | $29K | Sell |
311
-642
| -67% | -$59.9K | 0.01% | 357 |
|
2017
Q2 | $87K | Buy |
953
+620
| +186% | +$56.6K | 0.06% | 198 |
|
2017
Q1 | $29K | Buy |
333
+316
| +1,859% | +$27.5K | 0.02% | 262 |
|
2016
Q4 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 570 |
|
2016
Q3 | – | Sell |
-23
| Closed | -$2K | – | 248 |
|
2016
Q2 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 260 |
|